Sign in

CIK 0001488039

  • Non-accelerated filer
  • Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264753208
Phone
+1 206-588-0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-12 Steinhart Richard I Director Grant or award +10,000 10,000
2026-05-12 Chen Shu-Chih Director Grant or award +10,000 10,000
2026-05-12 Remmel H. Lawrence Director Grant or award +10,000 10,683
2026-05-12 Finn Jonathan Director Grant or award +10,000 11,666
2026-05-12 Galli Stephen J Director Grant or award +10,000 10,006
2026-05-12 Cigler Tessa Director Grant or award +10,000 10,000
2026-03-27 QUAY STEVEN C President & CEO Grant or award +65,000 88,038
2026-03-26 Daniel Mark James Chief Financial Officer Grant or award +63,000 63,000
2026-01-20 QUAY STEVEN C President & CEO Grant or award +331,674 345,572
2026-01-20 QUAY STEVEN C President & CEO Grant or award · Stock Options (right to buy) +950,000 $0.60 $573K 950,000
2026-01-20 QUAY STEVEN C President & CEO Grant or award +325,203 339,101
2026-01-20 QUAY STEVEN C President & CEO Grant or award · Stock Options (right to buy) +950,000 $0.60 $573K 950,000
2025-10-14 Daniel Mark James Chief Financial Officer Grant or award · Stock Option (right to buy) +578,000 578,000
2025-05-21 QUAY STEVEN C President & CEO Purchase +11,239 $0.88 $10K 13,898
2025-05-15 Finn Jonathan Director Grant or award · Stock Option (right to buy) +125,000 125,000
2025-05-15 Chen Shu-Chih Director Grant or award · Stock Option (right to buy) +125,000 125,000
2025-05-15 QUAY STEVEN C President & CEO Grant or award · Stock Option (right to buy) +1,366,062 1,366,062
2025-05-15 Rees Heather Chief Financial Officer Grant or award · Stock Option (right to buy) +543,785 543,785
2025-05-15 Galli Stephen J Director Grant or award · Stock Option (right to buy) +125,000 125,000
2025-05-15 Remmel H. Lawrence Director Grant or award · Stock Option (right to buy) +125,000 125,000

Page 1 of 9 · 168 trades